Status | Study |
COMPLETED |
Study Name: Validity and Reliability of the 6 Minute Pegboard Ring Test Condition: Duchenne Muscular Dystrophy Date: 2023-11-20 |
NOT_YET_RECRUITING |
Study Name: Remote Study: Wearable Technology to Evaluate Hyperglycemia and HRV in DMD Condition: Duchenne Muscular Dystrophy Date: 2023-11-03 Interventions: Three wearable devices |
NOT_YET_RECRUITING |
Study Name: Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy (FOX) Condition: Duchenne Muscular Dystrophy Date: 2023-10-20 Interventions: EDG-5506 is administered orally once per day |
RECRUITING |
Study Name: Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim Condition: Duchenne Muscular Dystrophy Date: 2023-10-10 Interventions: Three wearable devices |
RECRUITING |
Study Name: NSAA NON-Interventional Study Protocol Condition: Duchenne Muscular Dystrophy Date: 2023-09-12 Interventions: Remote Administration of NSAA |
NOT_YET_RECRUITING |
Study Name: NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2023-07-18 Interventions: Cohort 1:Part 1 Dose Level 1-3: a 4-week Treatment Phase at each treatment dose levelPart 2 Single Dose Level: a 24-week Treatment Ph |
RECRUITING |
Study Name: A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2023-05-19 Interventions: Single IV infusion of delandistrogene moxeparvovec |
RECRUITING |
Study Name: A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy. Condition: Duchenne Muscular Dystrophy Date: 2023-01-09 Interventions: gene therapy administered in a previous study. |
RECRUITING |
Study Name: AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) Condition: Duchenne Muscular Dystrophy Date: 2023-01-04 Interventions: RGX-202 is a recombinant AAV8 containing a transgene encoding a novel microdystrophin |
Active, not recruiting |
Study Name: Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions Condition: Duchenne Muscular Dystrophy Date: 2022-12-04 Interventions: Other: Modified Mini Mental Test:To assess the cognitive function of childrenOther: The Controlled Oral Word Association TestTo asse |